Federal grants to Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. in Boston, Massachusetts received $104 million in federal grants from fiscal 2021 to 2025, across 62 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $91.6 million. In fiscal 2025 it was awarded $22.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$104 million
- Awards62
- Awarded in FY 2025$22.2 million
- Largest award$8.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 33 | $16.5 million |
| FY 2022 | 33 | $20.5 million |
| FY 2023 | 37 | $20.5 million |
| FY 2024 | 42 | $24.6 million |
| FY 2025 | 37 | $22.2 million |
Programs that fund Joslin Diabetes Center, Inc.
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 45 | $91.6 million |
| Aging Research | 4 | $3.2 million |
| Biomedical Research and Research Training | 1 | $2.8 million |
| Vision Research | 1 | $1.9 million |
| Trans-NIH Research Support | 2 | $1.4 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $1.1 million |
| Child Health and Human Development Extramural Research | 2 | $868,096 |
| Cardiovascular Diseases Research | 3 | $863,791 |
| Minority Health and Health Disparities Research | 2 | $577,675 |
| Allergy and Infectious Diseases Research | 1 | $104,284 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 62 | $104 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Diabetes and endocrinology research center | Diabetes, Digestive, and Kidney Diseases Extramural Research | March 29, 2021 | $8.4 million |
| Epitranscriptomics in human obesity and type 2 diabetes - project summary dysfunction of multiple metabolic cells contribute to the pathophysiology of the two major pathological states, obesity and type 2 diabetes, which have a huge economic burden worldwide. Identifying the etiology of the two link | Diabetes, Digestive, and Kidney Diseases Extramural Research | June 27, 2024 | $4.0 million |
| Training grant in diabetes and metabolism | Diabetes, Digestive, and Kidney Diseases Extramural Research | October 1, 2020 | $3.8 million |
| Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk - project summary type 1 diabetes and its metabolic consequences continue to be among the most significant biomedical challenges in the us and worldwide today. In addition to morbidities speci | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 19, 2022 | $3.7 million |
| Exercise regulation of glucose homeostasis administrative supplement | Diabetes, Digestive, and Kidney Diseases Extramural Research | November 17, 2020 | $3.4 million |
| Developmental genes and the origin of fat | Diabetes, Digestive, and Kidney Diseases Extramural Research | March 12, 2021 | $3.3 million |
| Novel mechanisms for exercise training effects on glucose homeostasis | Diabetes, Digestive, and Kidney Diseases Extramural Research | December 15, 2020 | $3.3 million |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes - summary a large proportion of the excess cvd morbidity and mortality experienced by individuals with T1D occur in conjunction with diabetic kidney disease (DKD), which is associated with a striking increase in t | Diabetes, Digestive, and Kidney Diseases Extramural Research | December 24, 2021 | $3.2 million |
| Characterization of cardiovascular diseases (CVD) in people with long duration type 1 diabetes - abstract cardiovascular disease (CVD) is the major cause of mortality in type 1 diabetes (T1D). Some cvd risk factors are shared between people with T1D and type 2 diabetes (T2D). However, differences in | Diabetes, Digestive, and Kidney Diseases Extramural Research | December 24, 2021 | $3.2 million |
| Improving glycemia & reducing diabetes distress in adolescents & young adults with T1D - project summary/abstract adolescents and young adults (AYA) with type 1 diabetes (T1D) are especially at risk for missed diabetes visits and suboptimal self-care behaviors, as evidenced by their poor glycemic co | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 25, 2021 | $3.0 million |
Questions people ask
How much federal grant money does Joslin Diabetes Center, Inc. get?
$104 million in 62 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Joslin Diabetes Center, Inc. the most?
The Department of Health and Human Services, with $104 million in 62 awards.
What is Joslin Diabetes Center, Inc.'s largest federal grant?
$8.4 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on March 29, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Joslin Diabetes Center, Inc.?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Aging Research and Biomedical Research and Research Training.
Other grant recipients in Boston
- The Commonwealth of Massachusetts
- Massachusetts Department of Transportation
- Massachusetts Bay Transportation Authority
- Department of Transitional Assistan
- The General Hospital Corporation
- Massachusetts Department of Public Health
- Brigham & Womens Hospital Inc
- Executive Office of Housing and Livable Communities
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts